Item Details

C-006 / C-006-1MLUpdated item number format

Codeine
1.0 mg/mL in Methanol | Certified Reference Material

Codeine is an opiate used for its analgesic, antitussive, and sedative properties and is the second-most predominant alkaloid in opium. This certified reference solution is suitable for use as a starting material in calibrators and controls for LC/MS and GC/MS testing methods in clinical toxicology, forensic analysis, pharmaceutical research, and pain prescription monitoring. As a widely popular recreational drug, codeine is regulated under various narcotic control laws in countries such as Australia, New Zealand, Romania, Sweden, and the United States. Since opiates are classified as controlled substances, Cerilliant offers most opiate reference standards as DEA-exempt solutions for added convenience.

Concentration
:    1.0 mg/mL
Solvent
:    Methanol
Unit Size
:    1 mL/ampoule
CAS Number
:    76-57-3
Chemical Formula:
:    C18H21NO3
Molecular Weight:
:    299.36
Certificate of Analysis
US List Price
$29.60 EA
**All prices shown are for sales within US and Canada.**
Quantity
**Eligible Discounts Applied at Checkout**
Product Image
A-053 / A-053-1ML 6-Acetylcodeine, 1.0 mg/mL $66.40
C-005 / C-005-1ML Codeine-D3, 100 μg/mL $42.80
C-007 / C-007-1ML Codeine-D3, 1.0 mg/mL $164.00
C-015 / C-015-1ML Codeine, 100 μg/mL $34.90
C-040 / C-040-1ML Codeine-D6, 100 μg/mL $46.40
C-041 / C-041-1ML Codeine-D6, 1.0 mg/mL $185.00
C-087 / C-087-1ML Codeine-6-β-D-glucuronide, 100 μg/mL $190.00
C-126 / C-126-1ML Codeine-6β-D-glucuronide, 1.0 mg/mL $473.00
C-138 / C-138-1ML Codeine-6-ß-D-glucuronide-D3, 100 µg/mL $204.00
D-019 / D-019-1ML Dihydrocodeine HCl, 1.0 mg/mL (as free base) $29.60
D-021 / D-021-1ML Dihydrocodeine-D6 HCl, 100 μg/mL (as free base) $41.20
D-087 / D-087-1ML Dihydrocodeine-D6 HCl, 1.0 mg/mL (as free base) $417.00
N-005 / N-005-1ML Norcodeine, 1.0 mg/mL $46.10
O-020 / O-020-1ML Opiate Multi-Component Mixture-5, 250 μg/mL of each component $176.00
P-071 / P-071-1ML Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl $473.00
T-116 / T-116-1ML Thebaine, 1.0 mg/mL $80.90

Regulatory Control

▶  USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶  Canada Test Kit Registration # 61-1077 - no Health Canada import authorization required
Methods
method 1694

Recommended Storage Condition

Freeze

UN Number, Class, PG

1230, 3, II

Safety Data Sheet

HS Code

3822.90.0000
Advanced Toxicology Testing for Compounds using Core-Shell Technology | Erica A. Guice, Jessica Marsh, Seyed Sajadi, and Matthew Pentis, Western Slope Laboratory, 2012
An Automated Solid Phase Extraction Method for Opiates in Urine | Jeffery Hackett and Michael Telepchak, UCT, Inc., 2012
Comparison of Forensic Tandem Mass Spectral Data Obtained on Portable Instrumentation to an Established Reference Library | Adam E. O’Leary, Seth E. Hall, Herbert M. Oberacher, andChristopher C. Mulligan, llinois State University Department of Chemistry, 2014
Development of a high-throughput LC-MS/MS assay for pain management panel from urine | Hui Qiao, Changtong Hao, Sha Joshua Ye, Lisa Cousins, IONICS Mass Spectrometry Group inc., 2014
Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
LC-MS (TOF) Analysis of Opioids and Opiate-Dependence Management Drugs on Ascentis® Express HILIC | Sigma-Aldrich®, 2014
LC/MS (TOF) Analysis of Drugs and Their Glucuronide Metabolites on Titan™ C18 after Solid Phase Extraction (SPE) using Supel™-Select SCX, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
LC/MS/MS Analysis of Drugs of Abuse: Generic Screening on Ascentis® Express F5 | Sigma-Aldrich®, 2015
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
Rapid Differentiation of Isobaric Drugs Using a Novel Direct Sample Analysis Source, CID, and Accurate Mass TOF Mass Spectrometry | Robert J. Seward, Bonnie Marmor, and Andrew Tyler, PerkinElmer, Inc., 2014
Testing and Quantification of a Representative Panel of Illicit Drugs in Urine and Serum Using LC-Time-of-Flight Mass Spectrometry | Avinash Dalmia, Noelle M. Elliott, Joanne Mather, Bonnie Marmor, George Perkins;, PerkinElmer, Inc., 2014
Testing and Quantitation of Opioids in Urine and Serum by LC-TOF | Sharanya Reddy, Nonnie Danna, PerkinElmer Inc,, 2014
UHPLC/MS Analysis of Heroin and Related Compounds on Titan™ C18 | Sigma-Aldrich®, 2015
Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015